Accendra Health (ACH)
NYSE Market Closed
Accendra Health, Inc. is a healthcare services and medical products provider focused on care delivered outside traditional hospital settings. The company connects patients, clinicians, payers, and caregivers through a mix of distribution capabilities, home-based equipment, technology-enabled support, and recurring patient services. Its model is built around the growing demand for lower-cost, convenient care for people managing chronic, complex, or acute medical needs at home.
The company operates through brands including Apria and Byram Healthcare. Apria is associated with home respiratory care, sleep therapy, and durable medical equipment, supplying products such as oxygen systems, ventilation support, and continuous positive airway pressure equipment for obstructive sleep apnea. Byram Healthcare focuses on disposable medical supplies and patient support across categories such as diabetes management, ostomy care, wound care, urology, and incontinence.
Accendra Health serves a market shaped by ageing populations, rising chronic disease prevalence, and health systems that increasingly seek to shorten hospital stays and reduce readmissions. Its products and services support patients who require ongoing monitoring, consumables, training, or equipment maintenance after discharge or as part of long-term disease management.
The company’s distinctive role lies in combining national distribution scale with specialised clinical and administrative support. It helps coordinate insurance coverage, product fulfilment, and patient education, areas that can be difficult for individuals to navigate on their own. By operating across both durable equipment and recurring supply categories, Accendra Health occupies an important position in the home healthcare value chain, where reliability, reimbursement expertise, and patient adherence are central to outcomes.
Last updated
- Market Cap
- 206.78M
- P/E
- —
- P/FCF
- —
- P/S
- 0.08
- Enterprise Value
- 1.97B
- Sector
- Industrials
- Industry
- Medical, Dental, and Hospital Equipment and Supplies
- Address
- 4435 WATERFRONT DRIVE, GLEN ALLEN, VA
Leading Chinese companies announce delisting plans from the NYSE
Is Aluminum Corp. of China Limited (ACH) a Great Value Stock Right Now?
JD.com, Nio, XPeng and Pinduoduo added to list of Chinese companies at risk of expulsion from U.S. exchanges
Is Aluminum (ACH) Stock Outpacing Its Basic Materials Peers This Year?
Is Aluminum (ACH) Outperforming Other Basic Materials Stocks This Year?
Aluminum (ACH) is on the Move, Here's Why the Trend Could be Sustainable
Top Ranked Momentum Stocks to Buy for September 20th
New Strong Buy Stocks for September 20th
Aluminum (ACH) is a Great Momentum Stock: Should You Buy?
4 Non Ferrous Metal Mining Stocks Defying Industry Odds
Three Things to Focus On This Earnings Season
Recent Price Trend in Aluminum (ACH) is Your Friend, Here's Why
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 206.78M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.97B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -0.44
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.08
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 4.54
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.73
- EPS
- -14.13
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -350.8M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 232.83%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -44.79%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -4.53
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.49
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.43
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.28
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 864.57K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 2.7
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 627.78M | 708.97M | 697.26M | 681.92M | 673.88M |
| Gross profit | 278.03M | 323.26M | 322.2M | 324.6M | 319.24M |
| Operating income | 17.13M | 20.91M | 26.47M | -39.71M | 19.79M |
| EBITDA | 78.87M | 148.24M | 91.23M | 116.15M | 62.69M |
| Net income | -6.47M | -56.33M | -150.28M | -869.06M | -24.98M |
| Basic EPS | -0.08 | -0.76 | -1.94 | -11.3 | -0.32 |
| Diluted EPS | -0.08 | -0.76 | -1.94 | -11.3 | -0.32 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2.42B | 2.45B | 4.04B | 4.15B | 4.86B |
| Total liabilities | 2.88B | 2.91B | 4.47B | 4.44B | 4.29B |
| Total equity | -464.77M | -460.98M | -429.51M | -281.01M | 570.98M |
| Cash & equivalents | 336.88M | 281.99M | 32.84M | 38.26M | 59.44M |
| Current assets | 588.5M | 547.87M | 2.13B | 2.3B | 2.21B |
| Current liabilities | 1.2B | 947.08M | 1.12B | 1.21B | 1.96B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -50.08M | 68.19M | -172.52M | 37.61M | -35.07M |
| Investing cash flow | 53.93M | 285M | -39.46M | -52.92M | -48.2M |
| Financing cash flow | 51.08M | -117.5M | 181.1M | 31.7M | 92.78M |
| Change in cash | 54.89M | 235.82M | -30.92M | 17.65M | 10.05M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 8-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| form 4 | Form 4 — Galloway Heath H | View Filing | |
| edgar index | 8-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | S-8 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Bernocchi Perry A | View Filing | |
| form 4 | Form 4 — Galloway Heath H | View Filing | |
| form 4 | Form 4 — Pesicka Edward A | View Filing | |
| form 4 | Form 4 — Leon Jonathan A | View Filing | |
| edgar index | SCHEDULE 13G/A — ACCENDRA HEALTH INC/VA/ | View Filing | |
| form 4 | Form 4 — Beck Mark A | View Filing | |
| form 4 | Form 4 — Bingham Gwendolyn M | View Filing | |
| form 4 | Form 4 — Gardner-Smith Kenneth | View Filing | |
| form 4 | Form 4 — Klemash Stephen W | View Filing | |
| form 4 | Form 4 — Kline Teresa L. | View Filing | |
| edgar index | 8-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 10-Q — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 8-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | DEFA14A — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | ARS — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | SCHEDULE 13G — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | SCHEDULE 13G/A — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| form 4 | Form 4 — Galloway Heath H | View Filing | |
| form 4 | Form 4 — Bernocchi Perry A | View Filing | |
| form 4 | Form 4 — Leon Jonathan A | View Filing | |
| form 4 | Form 4 — Pesicka Edward A | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 4 — ACCENDRA HEALTH INC/VA/ | View Filing | |
| form 4 | Form 4 — Galloway Heath H | View Filing | |
| form 4 | Form 4 — Leon Jonathan A | View Filing | |
| form 4 | Form 4 — Bernocchi Perry A | View Filing | |
| edgar index | 10-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — ACCENDRA HEALTH INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 8-K/A — ACCENDRA HEALTH INC/VA/ | View Filing | |
| edgar index | 8-K — OWENS & MINOR INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OWENS & MINOR INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OWENS & MINOR INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OWENS & MINOR INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — OWENS & MINOR INC/VA/ | View Filing | |
| form 4 | Form 4 — Long Andrew G | View Filing | |
| form 4 | Form 4 — Long Andrew G | View Filing | |
| edgar index | SCHEDULE 13D — OWENS & MINOR INC/VA/ | View Filing | |
| edgar index | 10-Q — OWENS & MINOR INC/VA/ | View Filing | |
| edgar index | SCHEDULE 13G/A — OWENS & MINOR INC/VA/ | View Filing | |
| edgar index | 8-K — OWENS & MINOR INC/VA/ | View Filing | |
| eight k text | 8-K — 8-K | View Filing |